ArticleInternational journal of clinical and experimental medicine2013
Correlation between microalbuminuria and cardiovascular events.
Article in International journal of clinical and experimental medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.
- Microalbuminuria among HIV/AIDS patients in Africa: a systematic review and meta-analysis.BMC infectious diseases · 2025Pooled it
- Eicosapentaenoic and Docosahexaenoic Acids Attenuate Progression of Albuminuria in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease.Journal of the American Heart Association · 2017Trial
- Urinary albumin-to-creatinine ratio is associated with endothelial dysfunction in HIV-infected patients receiving antiretroviral therapy.Scientific reports · 2016Trial
- Nephrotoxicity of Phthalates: A Review Based on Epidemiological and Toxicological Evidence.Toxics · 2025Review
- Association between serum bilirubin levels and progression of albuminuria in Taiwanese with type 2 diabetes mellitus.Biomedical journal · 2021Article
- Association of Hypertension and Obesity with Risk Factors of Cardiovascular Diseases in Children Aged 6-9 Years Old in the Eastern Cape Province of South Africa.Children (Basel, Switzerland) · 2020Article
- New Areas of Interest: Is There a Role for Omega-3 Fatty Acid Supplementation in Patients With Diabetes and Cardiovascular Disease?Current diabetes reports · 2019Review
- Predictive factors and prevalence of microalbuminuria in HIV-infected patients: a cross-sectional analysis.BMC nephrology · 2017Observational
- Microalbuminuria in non-diabetic patients with unstable angina/non ST-segment elevation myocardial infarction.BMC research notes · 2015Article
- Association of epicardial adipose tissue, neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with diabetic nephropathy.International journal of clinical and experimental medicine · 2014Article
- Association of uric acid, atherogenic index of plasma and albuminuria in diabetes mellitus.International journal of clinical and experimental medicine · 2014Article
- Predictors of subclinical atherosclerosis evaluated by carotid intima-media thickness in asymptomatic young women with type 1 diabetes mellitus.Archives of endocrinology and metabolismArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to investigate the relationship between microalbuminuria (MAU) and cardiovascular events.
methodsA total of 1259 hospitalized patients who received urinary albumin detection were recruited from Tongji Hospital of Tongji University in 2012. They were divided into two groups according to the level of urinary albumin: normal albuminuria (NAU) group (n=907) and MAU group (n=352). General information and cardiovascular events were collected and further analyzed.
resultsPatients in MAU group was elder than those in NAU group (P<0.01), and the prevalence of diabetes and/or hypertension in MAU group was significantly higher than that in NAU group (P<0.01). The prevalence of major cardiovascular events (unstable angina, non-ST-segment elevation myocardial infarction and ST-segment elevation myocardial infarction) and congestive heart failure requiring therapy in hospital in MAU group was significantly higher than that in NAU group (P<0.01). Logistic regression analysis showed patients in MAU group had higher risk for major cardiovascular events (OR 1.438, 95% CI 1.018-2.031) and congestive heart failure (OR 2.540, 95% CI 1.717 to 3.757).
conclusionsMAU increases the risk for major cardiovascular events and congestive heart failure. MAU is an independent risk factor of cardiovascular events. Patients with MAU (30-300 mg/24 h) should be treated timely to reduce the incidence of cardiovascular events and delay the progression of cardiovascular diseases, which is independent of presence of diabetes and/or hypertension.
Indexed as
Identifiers
24260606PMC3832337W1590417197What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.